ЕРИТРОПОЕТИН ЯК НЕЗАЛЕЖНИЙ ПРОГНОСТИЧНИЙ ФАКТОР У ХВОРИХ НА МІЄЛОДИСПЛАСТИЧНІ СИНДРОМИ

• Date: 2023
• Main Authors: Boyko, O., Simonova, M., Knysh, N., Danysh, O., Vygovska, Y., Masliak, Z.
• Format: Article
• Language: English
• Published: PH Akademperiodyka 2023
• Subjects: мієлодиспластичні синдроми; анемія; еритропоетин; виживаність.
• Online Access: https://exp-oncology.com.ua/index.php/Exp/article/view/2021-1-11
• Journal Title: Experimental Oncology

Aim: To assess the level of erythropoietin (EPO) in blood sera of patients with different subtypes of myelodysplastic syndromes (MDS) from different risk subgroups and to determine its prognostic role. Materials and Methods: EPO was measured by enzyme-linked immunosorbent assay in peripheral blood o...